Jiangsu Jibeier Pharmaceutical Co., Ltd.
SSE:688566.SS
28.15 (CNY) • At close June 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| 218.976 | 218.768 | 154.263 | 114.347 | 129.857 | 112.784 | 96.918 | 77.61 | 77.853 |
| Depreciation & Amortization
| 10.698 | 12.278 | 12.751 | 12.98 | 13.298 | 12.809 | 12.351 | 12.524 | 11.631 |
| Deferred Income Tax
| 0 | 0 | -0.472 | -0.803 | -4.393 | -0.325 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 17.893 | 20.976 | 7.153 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -63.065 | -99.245 | -33.945 | 33.843 | -11.82 | -11.34 | -9.75 | 19.846 | -53.744 |
| Accounts Receivables
| -24.284 | -138.143 | -72.076 | 42.96 | -57.206 | -21.905 | -10.376 | 12.771 | -47.224 |
| Inventory
| -1.185 | 1.12 | -0.831 | 0.28 | -2.907 | 2.332 | -5.436 | 7.218 | -2.368 |
| Accounts Payables
| 0 | 38.468 | 39.434 | -8.595 | 52.685 | 8.559 | 0 | 0 | 0 |
| Other Working Capital
| -37.596 | -0.69 | -0.472 | -0.803 | -4.393 | -0.325 | -4.314 | 12.628 | -51.376 |
| Other Non Cash Items
| 48.685 | 9.807 | -3.381 | -16.963 | -13.972 | 1.196 | -1.551 | 1.678 | 3.548 |
| Operating Cash Flow
| 215.294 | 159.5 | 150.724 | 150.557 | 117.363 | 115.449 | 97.966 | 111.658 | 39.288 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -174.53 | -357.374 | -292.704 | -83.787 | -23.682 | -30.215 | -8.194 | -18.778 | -46.685 |
| Acquisitions Net
| 0 | 0 | 0.006 | 0.001 | 0.001 | 0.002 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | -70 | -11.2 | -60 | -2,465 | -106.809 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 1,204.433 | 5.076 | 11.77 | 20.637 | 17.881 | 0.664 | 2.907 | 0.834 | 0.254 |
| Other Investing Activites
| -1,250.076 | 58.258 | 116.639 | -210 | 2,465 | 106.809 | 0 | -1.638 | 20.553 |
| Investing Cash Flow
| -220.173 | -364.039 | -175.49 | -333.149 | -5.8 | -29.549 | -5.287 | -19.582 | -25.878 |
| Financing Activities: | |||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -19 | -10 |
| Common Stock Issued
| 0 | -0.4 | 0 | 0 | -10.99 | -6.559 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -102.95 | -44.866 | -89.732 | -89.732 | -44.866 | -10.858 | -169.142 | -5.015 | -3.677 |
| Other Financing Activities
| 261.558 | 43.635 | 0 | 0 | 1,038.275 | -6.559 | 0 | 0 | 0 |
| Financing Cash Flow
| 157.298 | -1.231 | -89.732 | -89.732 | 982.419 | -17.417 | -169.142 | -24.015 | -13.677 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | -0 | 0 | -0 | 0 | 0 | -0 |
| Net Change In Cash
| 152.419 | -205.77 | -114.498 | -272.324 | 1,093.982 | 68.483 | -76.463 | 68.061 | -0.267 |
| Cash At End Of Period
| 846.86 | 694.442 | 900.212 | 1,014.71 | 1,287.034 | 193.052 | 124.569 | 201.032 | 132.971 |